Melatonin contributes to the seasonality of multiple sclerosis relapses

Authors
Farez, Mauricio; Mascanfroni, Ivan Darío; Mendez Huergo, Santiago Patricio; Yeste, Ada; Murugaiyan, Gopal; Garo, Lucien P.; Balbuena Aguirre, María E.; Patel, Bonny; Ysrraelit, María C.; Zhu, Chen; Kuchroo, Vjay K.; Rabinovich, Gabriel Adrian; Quintana, Francisco; Correale, Jorge
Publication Year
2015
Language
English
Format
article
Status
Published version
Description
Seasonal changes in disease activity have been observed in multiple sclerosis, an autoimmune disorder that affects the CNS. These epidemiological observations suggest that environmental factors influence the disease course. Here, we report that melatonin levels, whose production is modulated by seasonal variations in night length, negatively correlate with multiple sclerosis activity in humans. Treatment with melatonin ameliorates disease in an experimental model of multiple sclerosis and directly interferes with the differentiation of human and mouse T cells. Melatonin induces the expression of the repressor transcription factor Nfil3, blocking the differentiation of pathogenic Th17 cells and boosts the generation of protective Tr1 cells via Erk1/2 and the transactivation of the IL-10 promoter by ROR-α. These results suggest that melatonin is another example of how environmental-driven cues can impact T cell differentiation and have implications for autoimmune disorders such as multiple sclerosis.
Fil: Farez, Mauricio. Fundacion para la Lucha contra las Enfermedades Neurologicas Infancia. Instituto de Investigaciones Neurologicas "Raul Carrea"; Argentina
Fil: Mascanfroni, Ivan Darío. Harvard Medical School; Estados Unidos
Fil: Mendez Huergo, Santiago Patricio. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental (i); Argentina
Fil: Yeste, Ada. Harvard Medical School; Estados Unidos
Fil: Murugaiyan, Gopal. Harvard Medical School; Estados Unidos
Fil: Garo, Lucien P.. Harvard Medical School; Estados Unidos
Fil: Balbuena Aguirre, María E.. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina. Fundacion para la Lucha contra las Enfermedades Neurologicas Infancia. Instituto de Investigaciones Neurologicas "Raul Carrea"; Argentina
Fil: Patel, Bonny. Harvard Medical School; Estados Unidos
Fil: Ysrraelit, María C.. Fundacion para la Lucha contra las Enfermedades Neurologicas Infancia. Instituto de Investigaciones Neurologicas "Raul Carrea"; Argentina
Fil: Zhu, Chen . Harvard Medical School; Estados Unidos
Fil: Kuchroo, Vjay K.. Harvard Medical School; Estados Unidos
Fil: Rabinovich, Gabriel Adrian. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental (i); Argentina. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina
Fil: Quintana, Francisco. Harvard Medical School; Estados Unidos
Fil: Correale, Jorge. Fundacion para la Lucha contra las Enfermedades Neurologicas Infancia. Instituto de Investigaciones Neurologicas "Raul Carrea"; Argentina
Subject
MELATONIN
MULTIPLE SCLEROSIS
AUTOIMMUNITY
CELL DIFFERENTIATION
ENCEPHALOMYELITIS AUTOIMMUNE EXPERIMENTAL
Inmunología
Medicina Básica
CIENCIAS MÉDICAS Y DE LA SALUD
Access level
Restricted access
License
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
Repository
CONICET Digital (CONICET)
Institution
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identifier
oai:ri.conicet.gov.ar:11336/7741